Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Longboard Pharmaceuticals Stock

Own Longboard Pharmaceuticals stock in just a few minutes.

Longboard Pharmaceuticals, Inc
-$0.06 (-0.66%)

Longboard Pharmaceuticals, Inc is a biotechnology business based in the US. Longboard Pharmaceuticals shares (LBPH) are listed on the NASDAQ and all prices are listed in US Dollars. Longboard Pharmaceuticals employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Longboard Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LBPH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Longboard Pharmaceuticals stock price (NASDAQ: LBPH)

Use our graph to track the performance of LBPH stocks over time.

Longboard Pharmaceuticals shares at a glance

Information last updated 2021-07-28.
Latest market close$8.26
52-week range$7.69 - $17.60
50-day moving average $8.90
200-day moving average $10.73
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Longboard Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Longboard Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Longboard Pharmaceuticals price performance over time

Historical closes compared with the close of $8.26 from 2021-05-28

1 week (2021-07-21) N/A
1 month (2021-07-01) -9.13%
3 months (2021-04-30) -13.33%
6 months (2021-01-28) N/A
1 year (2020-07-28) N/A
2 years (2019-07-28) N/A
3 years (2018-07-28) N/A
5 years (2016-07-28) N/A

Longboard Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $7.22
Market capitalisation $161.3 million

TTM: trailing 12 months

Shorting Longboard Pharmaceuticals shares

There are currently 56,119 Longboard Pharmaceuticals shares held short by investors – that's known as Longboard Pharmaceuticals's "short interest". This figure is 30.8% up from 42,890 last month.

There are a few different ways that this level of interest in shorting Longboard Pharmaceuticals shares can be evaluated.

Longboard Pharmaceuticals's "short interest ratio" (SIR)

Longboard Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Longboard Pharmaceuticals shares currently shorted divided by the average quantity of Longboard Pharmaceuticals shares traded daily (recently around 114528.57142857). Longboard Pharmaceuticals's SIR currently stands at 0.49. In other words for every 100,000 Longboard Pharmaceuticals shares traded daily on the market, roughly 490 shares are currently held short.

To gain some more context, you can compare Longboard Pharmaceuticals's short interest ratio against those of similar companies.

However Longboard Pharmaceuticals's short interest can also be evaluated against the total number of Longboard Pharmaceuticals shares, or, against the total number of tradable Longboard Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Longboard Pharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Longboard Pharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0.0098% of the tradable shares (for every 100,000 tradable Longboard Pharmaceuticals shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Longboard Pharmaceuticals.

Find out more about how you can short Longboard Pharmaceuticals stock.

Longboard Pharmaceuticals share dividends

We're not expecting Longboard Pharmaceuticals to pay a dividend over the next 12 months.

You may also wish to consider:

Longboard Pharmaceuticals overview

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020.

Frequently asked questions

What percentage of Longboard Pharmaceuticals is owned by insiders or institutions?
Currently 31.849% of Longboard Pharmaceuticals shares are held by insiders and 75.478% by institutions.
How many people work for Longboard Pharmaceuticals?
Latest data suggests 12 work at Longboard Pharmaceuticals.
When does the fiscal year end for Longboard Pharmaceuticals?
Longboard Pharmaceuticals's fiscal year ends in December.
Where is Longboard Pharmaceuticals based?
Longboard Pharmaceuticals's address is: 6154 Nancy Ridge Drive, San Diego, CA, United States, 92121

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site